当前位置:首页 - 行情中心 - 人福医药(600079) - 财务分析 - 现金流量表

人福医药

(600079)

  

流通市值:328.31亿  总市值:348.84亿
流通股本:15.36亿   总股本:16.32亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金23,400,444,143.5216,649,693,261.7610,869,441,951.254,967,884,802.38
收到的税费返还65,570,107.3349,058,696.1633,953,556.2516,023,713.55
收到其他与经营活动有关的现金757,909,068.67566,723,065.68543,963,173.53161,271,093.46
经营活动现金流入的平衡项目0000
经营活动现金流入小计24,223,923,319.5217,265,475,023.611,447,358,681.035,145,179,609.39
购买商品、接受劳务支付的现金12,442,441,863.18,905,989,317.185,847,263,294.442,865,208,186.05
支付给职工以及为职工支付的现金3,071,943,865.752,350,422,780.351,653,500,502.851,043,665,353.29
支付的各项税费1,826,392,820.091,354,272,980.36913,538,224.82405,401,606.73
支付其他与经营活动有关的现金4,915,895,045.433,681,411,711.632,648,137,591.211,348,982,019.36
经营活动现金流出的平衡项目0000
经营活动现金流出小计22,256,673,594.3716,292,096,789.5211,062,439,613.325,663,257,165.43
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,967,249,725.15973,378,234.08384,919,067.71-518,077,556.04
二、投资活动产生的现金流量:
收回投资收到的现金898,049,431.53886,320,601.74166,509,894.01127,883,750
取得投资收益收到的现金80,436,976.2151,288,311.6749,672,331.5344,270,414.8
处置固定资产、无形资产和其他长期资产收回的现金净额45,029,038.4323,903,478.1616,641,793.4413,426,217.07
处置子公司及其他营业单位收到的现金净额35,478,99235,478,99220,000,000-
收到的其他与投资活动有关的现金179,900,00088,700,00053,300,0001,000,000
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,238,894,438.171,085,691,383.57306,124,018.98186,580,381.87
购建固定资产、无形资产和其他长期资产支付的现金1,958,319,850.541,457,790,437.07877,435,422.3402,102,954
投资支付的现金338,251,875.33280,805,890.41280,805,890.411,750,000
支付其他与投资活动有关的现金167,041,119.5107,728,619.583,244,423.58360,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,463,612,845.371,846,324,946.981,241,485,736.29404,212,954
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,224,718,407.2-760,633,563.41-935,361,717.31-217,632,572.13
三、筹资活动产生的现金流量:
吸收投资收到的现金8,240,0005,200,0005,200,0002,660,000
其中:子公司吸收少数股东投资收到的现金8,240,0005,200,0005,200,0002,660,000
取得借款收到的现金9,468,533,963.956,855,727,849.385,023,606,130.982,300,396,130.98
收到其他与筹资活动有关的现金1,172,364,068.17904,827,118.41773,239,236.07762,743,362.07
筹资活动现金流入平衡项目0000
筹资活动现金流入小计10,649,138,032.127,765,754,967.795,802,045,367.053,065,799,493.05
偿还债务支付的现金10,137,516,080.976,761,467,815.974,972,424,039.823,255,408,730.72
分配股利、利润或偿付利息支付的现金668,564,989.68553,757,281.23462,180,069.67126,817,309.22
其中:子公司支付给少数股东的股利、利润80,876,316.4773,564,336.5968,988,801.7630,024,367.36
支付其他与筹资活动有关的现金1,948,624,402.561,352,963,505.42984,247,091.03406,509,136.12
筹资活动现金流出平衡项目0000
筹资活动现金流出小计12,754,705,473.218,668,188,602.626,418,851,200.523,788,735,176.06
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-2,105,567,441.09-902,433,634.83-616,805,833.47-722,935,683.01
四、汇率变动对现金及现金等价物的影响16,299,425.1319,299,361.825,497,678.58-7,964,666.98
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,346,736,698.01-670,389,602.36-1,141,750,804.49-1,466,610,478.16
加:期初现金及现金等价物余额4,337,181,241.184,337,181,241.184,337,181,241.184,337,181,241.18
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,990,444,543.173,666,791,638.823,195,430,436.692,870,570,763.02
补充资料:
净利润2,815,265,811.7-1,690,687,483.37-
资产减值准备61,407,302.82-29,215,446.98-
固定资产和投资性房地产折旧618,619,499.56-284,274,266.8-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧618,619,499.56-284,274,266.8-
无形资产摊销170,134,057.02-80,671,336.62-
长期待摊费用摊销13,424,023.8-6,448,145.53-
处置固定资产、无形资产和其他长期资产的损失1,084,924.95--37,940.24-
固定资产报废损失3,059,250.65-1,876,456.73-
公允价值变动损失-136,854,734.94--88,927,090.76-
财务费用323,151,227.07-113,280,417.37-
投资损失-215,660,937.04--192,073,716.93-
递延所得税14,001,981.02--25,515,187.06-
其中:递延所得税资产减少-6,267,031.2--9,915,306.51-
递延所得税负债增加20,269,012.22--15,599,880.55-
存货的减少-200,362,243.13-35,849,398.35-
经营性应收项目的减少-1,070,472,679.79--1,686,420,848.08-
经营性应付项目的增加-643,325,715.89-47,316,974.74-
其他43,181,088.32-28,470,478.92-
现金的期末余额2,990,444,543.17-3,195,430,436.69-
减:现金的期初余额4,337,181,241.18-4,337,181,241.18-
公告日期2024-03-292023-10-272023-08-252023-04-28
审计意见(境内)标准无保留意见
TOP↑